The recent Myriad U.S. Supreme Court decision has limited the patentability of biotechnology and life sciences inventions. In light of the Myriad decision, the USPTO has institute...
READ MOREtraverselegal - September 22, 2014 - Patent
The recent Myriad U.S. Supreme Court decision has limited the patentability of biotechnology and life sciences inventions. In light of the Myriad decision, the USPTO has institute...
READ MOREWe’re here to field your questions and concerns. If you are a company able to pay a reasonable legal fee each month, please contact us today.